Xeris Pharmaceuticals Inc. (XERS) Tops Q4 EPS by 3c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: XERS) | Delayed: 10.46 +0.11 (1.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.35 | 52 Week High | $ | |||
| Open | $10.52 | 52 Week Low | $ | |||
| Day High | $10.71 | P/E | N/A | |||
| Day Low | $10.15 | EPS | $ | |||
| Volume | 3,152,865 | |||||
